Profound Medical Corp. (PROF) stock
Close on Nov 11, 2026Market cap $286.78MP/E –Yield –
Profound Medical Corp. grew revenue 65.3% to $23.63M over the twelve months to Sep 30, 2026. Free cash flow was -$38.38M. At the latest close the market valued the company at $286.78M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $286.78M
- P/E ratio
- –
- Price to sales
- 12.14
- Price to book
- 6.75
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $23.63M
- Net income
- -$32.49M
- EPS, diluted
- $1.41
- Free cash flow
- -$38.38M
- Book value per share
- $1.16
- Diluted shares
- 37M
Trading
- Next earnings
- Mar 4, 2027 (estimated, after the close)
- Previous close
- $7.68
- Open
- $7.62
- Day's range
- $7.56 – $7.95
- Volume
- 147,149
- Average volume (20 days)
- 201,115
- Beta (5 years)
- 1.03
- 52-week range
- $4.80 – $8.95
- RSI (14 days)
- 71.2
- Volatility (1 year)
- 69.0%
- Relative volume
- 0.81×
- WACC
- 9.9%
Market cap history
Month-end market cap since 2019, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | PROF | S&P 500 | Difference | PROF per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +13.8% | -2.4% | +16.2 pts | ||
| 3 months | +12.5% | -1.2% | +13.6 pts | ||
| Year to date | -0.3% | +12.3% | −12.5 pts | ||
| 1 year | +22.2% | +12.4% | +9.7 pts | ||
| 3 years | -11.8% | +78.8% | −90.6 pts | -4.1% | +21.4% |
| 5 years | -34.0% | +75.2% | −109.1 pts | -8.0% | +11.9% |
| 10 years | +12.5% | +311.1% | −298.6 pts | +1.2% | +15.2% |
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Profound Medical filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Update
- Update
- Update
- Update
About Profound Medical
Surgical & Medical Instruments & Apparatus
Profound Medical is a commercial-stage medical technology company that develops and markets incision-free, magnetic resonance imaging-guided thermal ablation systems for diseased tissue. Its core product, the TULSA-PRO system, delivers robotically driven ultrasound to treat benign and malignant prostate conditions, including prostate cancer and benign prostatic hyperplasia. The company also provides the Sonalleve system, which utilizes focused ultrasound to treat uterine fibroids, osteoid osteoma, and bone metastases. Profound operates through capital equipment sales and recurring revenue from single-use procedural devices and maintenance services. Its customer base consists primarily of specialized physicians, such as urologists and radiologists, at hospitals and outpatient imaging facilities.
Company profile, executives and historyProfound Medical stock: common questions
What is Profound Medical's stock price?
PROF closed at $7.85 on Nov 11, 2026, up 2.21% on the day. Over the past 52 weeks it traded between $4.80 and $8.95.
What is Profound Medical's market cap?
Profound Medical was worth $286.78M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
How much revenue does Profound Medical make?
Profound Medical reported revenue of $23.63M for the twelve months to Sep 30, 2026, up 65.3% from a year earlier.
Does Profound Medical pay a dividend?
No. Profound Medical has not paid a cash dividend over the last twelve months.
When does Profound Medical report earnings next?
Profound Medical is expected to report Q4 FY2026 results on Mar 4, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has PROF stock performed over the past year?
Including dividends, PROF returned +22.2% over the past year, against +12.4% for the S&P 500.
How many PROF shares are sold short?
2M shares were sold short at the latest FINRA report, 4.40% of the float, or 9.8 days of average trading volume.
Who are Profound Medical's competitors?
Companies most similar to Profound Medical by business, industry and size include BDMD, SRTS, PLSM, HYPR, FOCL.
See a number that looks wrong?